Subspecialty Fellowship (PGY7) in Pediatric Sickle Cell Disease

The Center for Sickle Cell Anemia at University Hospitals Rainbow Babies & Children’s is now accepting applications for a specialized Fellowship in Pediatric Sickle Cell Disease for the 2024-2025 academic year. The Center for Sickle Cell Anemia is a unique partnership between the Angie Fowler Adolescent & Young Adult Cancer Institute and the UH Seidman Cancer Center, providing comprehensive care for children, adolescents, young adults, and adults with sickle cell disease. Led by Dr. Amma Owusu-Ansah, pediatric hematologist, the program is home to Northeast Ohio’s largest population of pediatric patients with Sickle Cell disease and provides a model transition program through which patients matriculate to care at the UH Seidman Cancer Center led by pediatric hematologist, Dr. Samuel Anim. UH Rainbow is a designated Center of Excellence for provision of gene therapy for Sickle Cell Disease, with access to FDA approved therapies as well as investigational therapies though multiple industry-sponsored clinical trials. University Hospitals provides a robust environment for clinical research, with access to resources through one of the nation’s largest Clinical and Translational Science Collaboratives (CTSCs) funded by the National Institutes of Health. Candidates will have access to funding to support the pursuit of either a Master’s in Clinical Research, or a Master’s in Public Health, and an opportunity to actively engage in translational research.

How to Apply

Interested applicants should send a CV, a short personal statement and 3 letters of recommendation to John Letterio, MD, Division Chief: John.Letterio@UHhospitals.org and copy to Administrative Assistant, Suzanne Fortunato: Suzanne.Fortunato@UHhospitals.org.

Eligibility Criteria

• Eligible / obtain an Ohio medical license.
• Completed either Pediatrics or Internal Medicine/Pediatrics Residency.
• Completed Pediatric Hematology Oncology Fellowship prior to matriculation.
• American Board of Pediatrics Eligible or certified in Pediatric Hematology Oncology prior to matriculation.
• If not a U.S. citizen or permanent resident, able to obtain a current J-1 or H1B VISA.

Program Description and Highlights

• Customized curriculum to accommodate fellow’s individual interests and background.
• Participation in research, including basic, clinical or translational, focused on the treatment and biology of Sickle Cell Disease, and on management of disease-related complications.
• Opportunity to lead a Quality Improvement project.
• Extensive, in-depth training in Sickle Cell Disease and in the diagnosis and on the diagnosis and management of complications of Sickle Cell Disease.
• Opportunities for elective experience in management of Adult Sickle Cell Disease.
• Engagement with cell therapy and bone marrow transplant providers collaborating in the care of patients with Sickle Cell Disease.